10.01 - Respiratory Infections 2021
DOI: 10.1183/23120541.lsc-2021.39
|View full text |Cite
|
Sign up to set email alerts
|

Clinical profile of 116 patients undergoing post-COVID follow-up - A prospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Long covid is defined as a condition of persisting symptoms for at least 3 months after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [ 2 ]. Even though an infection with SARS-CoV-2 results in mild coronavirus disease 2019 (COVID-19) in approximately 80% of the cases [ 2 ], up to 30% report persistent symptoms regardless of COVID-19 severity [ 3 ]. The most common symptoms reported by 40–70% of patients with LC are fatigue, shortness of breath/dyspnoea and muscle pain/post-exertional malaise, as well as brain fog, headache, memory issues, tachycardia and [ [3] , [4] , [5] , [6] ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Long covid is defined as a condition of persisting symptoms for at least 3 months after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [ 2 ]. Even though an infection with SARS-CoV-2 results in mild coronavirus disease 2019 (COVID-19) in approximately 80% of the cases [ 2 ], up to 30% report persistent symptoms regardless of COVID-19 severity [ 3 ]. The most common symptoms reported by 40–70% of patients with LC are fatigue, shortness of breath/dyspnoea and muscle pain/post-exertional malaise, as well as brain fog, headache, memory issues, tachycardia and [ [3] , [4] , [5] , [6] ].…”
Section: Introductionmentioning
confidence: 99%
“…Even though an infection with SARS-CoV-2 results in mild coronavirus disease 2019 (COVID-19) in approximately 80% of the cases [ 2 ], up to 30% report persistent symptoms regardless of COVID-19 severity [ 3 ]. The most common symptoms reported by 40–70% of patients with LC are fatigue, shortness of breath/dyspnoea and muscle pain/post-exertional malaise, as well as brain fog, headache, memory issues, tachycardia and [ [3] , [4] , [5] , [6] ]. Numerous different mechanisms have been studied to explain LC, varying from psychological to biological mechanisms including clotting/coagulation issues and disrupted brainstem/vagus nerve signaling, among others [ 7 ].…”
Section: Introductionmentioning
confidence: 99%